Laboratoires Euromedis Société anonyme (EPA:ALEMG)

EPA:ALEMG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.67	15.18	-	26.8	31.86
Cash & Short-Term Investments	16.67	15.18	-	26.8	31.86
Cash Growth	9.83%	-	-	-15.88%	102.48%
Accounts Receivable	9.73	7.75	8.51	8.85	14.04
Other Receivables	1.05	0.89	1.08	2.29	5.12
Receivables	10.77	8.64	9.59	11.14	19.15
Inventory	10.78	13.77	10.81	12.59	11.76
Prepaid Expenses	0.02	0.06	0.06	0.18	0.16
Other Current Assets	0	0	18.84	1.17	1.47
Total Current Assets	38.24	37.65	39.3	51.87	64.41
Property, Plant & Equipment	0.69	0.81	0.63	4.32	4.4
Long-Term Investments	0.2	0.21	6.21	0.88	0.9
Goodwill	-	-	-	2.54	2.63
Other Intangible Assets	0.3	0.05	0.03	0.09	0.14
Other Long-Term Assets	0.06	0.06	0.09	0.16	0.25
Total Assets	39.49	38.79	46.26	59.87	72.72

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	9.92	9.54	7.81	7.31	10.5
Accrued Expenses	-	-	-	1.61	1.86
Short-Term Debt	-	-	-	0	0.54
Current Portion of Long-Term Debt	0.99	-	-	-	-
Current Income Taxes Payable	1.44	1.12	1.1	-	-
Current Unearned Revenue	-	-	-	0.03	0.21
Other Current Liabilities	-	-	-	0.52	0.31
Total Current Liabilities	12.36	10.66	8.9	9.48	13.42
Long-Term Debt	5.11	8.04	10.02	12.73	14.63
Long-Term Leases	-	-	-	0.11	0.36
Long-Term Unearned Revenue	-	-	-	0.07	0.24
Long-Term Deferred Tax Liabilities	-	-	-	0.33	0.35
Other Long-Term Liabilities	5.61	3.61	4.75	2.27	2.48
Total Liabilities	23.08	22.3	23.67	24.99	31.48

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.77	5.75	5.75	6.02	6.02
Additional Paid-In Capital	9.76	9.73	9.73	9.21	9.21
Retained Earnings	-1.76	-1.63	4.48	-5.93	2.26
Treasury Stock	-	-	-	-0.42	-0.21
Comprehensive Income & Other	2.63	2.63	2.63	25.82	23.72
Total Common Equity	16.41	16.48	22.59	34.7	41
Minority Interest	-	-	-	0.18	0.24
Shareholders' Equity	16.41	16.48	22.59	34.88	41.24
Total Liabilities & Equity	39.49	38.79	46.26	59.87	72.72

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	6.11	8.04	10.02	12.84	15.53
Net Cash (Debt)	10.57	7.14	-10.02	13.96	16.33
Net Cash Growth	47.91%	-	-	-14.49%	-
Net Cash Per Share	3.70	2.51	-3.52	4.78	4.56
Filing Date Shares Outstanding	2.86	2.84	2.85	2.92	2.99
Total Common Shares Outstanding	2.86	2.84	2.85	2.92	2.99
Working Capital	25.88	26.99	30.39	42.39	50.99
Book Value Per Share	5.75	5.80	7.93	11.87	13.71
Tangible Book Value	16.11	16.43	22.56	32.07	38.23
Tangible Book Value Per Share	5.64	5.78	7.92	10.97	12.78
Land	0.27	-	-	0.32	0.32
Buildings	0.61	-	-	3.56	3.51
Machinery	-	-	-	7.04	6.61
Construction In Progress	0.02	-	-	0.11	0.1

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 4, 2026

Data Sources Report a data error